Anti-CD19 CAR T cells for refractory myasthenia gravis

Haghikia A, Hegelmaier T, Wolleschak D, Böttcher M, Desel C, Borie D, Motte J, Schett G, Schroers R, Gold R, Mougiakakos D (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Lancet Neurology Elsevier: Lancet

Book Volume: 22

Pages Range: 1104-1105

Journal Issue: 12

DOI: 10.1016/S1474-4422(23)00375-7

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Universitätsklinikum Magdeburg A.ö.R. DE Germany (DE) Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Kyverna Therapeutics, Inc. US United States (USA) (US) Ruhr-Universität Bochum (RUB) DE Germany (DE)

How to cite

APA:

Haghikia, A., Hegelmaier, T., Wolleschak, D., Böttcher, M., Desel, C., Borie, D.,... Mougiakakos, D. (2023). Anti-CD19 CAR T cells for refractory myasthenia gravis. Lancet Neurology, 22(12), 1104-1105. https://dx.doi.org/10.1016/S1474-4422(23)00375-7

MLA:

Haghikia, Aiden, et al. "Anti-CD19 CAR T cells for refractory myasthenia gravis." Lancet Neurology 22.12 (2023): 1104-1105.

BibTeX: Download